Mirae Asset Global ETFs Holdings’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,015
Closed -$22.3K 3296
2026
Q1
$22.3K Buy
6,015
+176
+3% +$739 ﹤0.01% 3035
2025
Q4
$20.1K Buy
5,839
+176
+3% +$702 ﹤0.01% 3049
2025
Q3
$28.9K Sell
5,663
-9,394
-62% -$49K ﹤0.01% 3025
2025
Q2
$79.7K Sell
15,057
-157
-1% -$1.14K ﹤0.01% 2716
2025
Q1
$124K Buy
15,214
+624
+4% +$5.83K ﹤0.01% 2533
2024
Q4
$187K Buy
14,590
+608
+4% +$7.17K ﹤0.01% 2415
2024
Q3
$150K Buy
13,982
+966
+7% +$9.07K ﹤0.01% 2515
2024
Q2
$103K Buy
+13,016
New +$124K ﹤0.01% 2549

Other funds holding RCEL

Mirae Asset Global ETFs Holdings's RCEL Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Avita Medical (RCEL) in Q2 2026, closing a stake of 6,015 shares — an estimated $22.3K sold.

Mirae Asset Global ETFs Holdings first reported a position in RCEL in Q2 2024 and held it in 8 quarters. The position peaked at $187K in Q4 2024. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Avita Medical position as of Q2 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 6,015 Avita Medical shares in Q2 2026, an estimated $22.3K.
  • Mirae Asset Global ETFs Holdings first reported a position in Avita Medical in Q2 2024 and held it in 8 quarters.
  • Mirae Asset Global ETFs Holdings's Avita Medical position peaked at $187K in Q4 2024.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.